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Abstract
Background: In a previous study, it was demonstrated that high replication of Porcine circovirus
2 (PCV2) in a gnotobiotic pig was correlated with the absence of PCV2-neutralizing antibodies. The
aim of the present study was to investigate if this correlation could also be found in SPF pigs in
which PMWS was experimentally reproduced and in naturally PMWS-affected pigs.
Results: When looking at the total anti-PCV2 antibody titres, PMWS-affected and healthy animals
seroconverted at the same time point, and titres in PMWS-affected animals were only slightly lower
compared to those in healthy animals. In healthy animals, the evolution of PCV2-neutralizing
antibodies coincided with that of total antibodies. In PMWS-affected animals, neutralizing
antibodies could either not be found (sera from field studies) or were detected in low titres
between 7 and 14 DPI only (sera from experimentally inoculated SPF pigs). Differences were also
found in the evolution of specific antibody isotypes titres against PCV2. In healthy pigs, IgM
antibodies persisted until the end of the study, whereas in PMWS-affected pigs they quickly
decreased or remained present at low titres. The mean titres of other antibody isotypes (IgG1,
IgG2 and IgA), were slightly lower in PMWS-affected pigs compared to their healthy group mates
at the end of each study.
Conclusion:  This study describes important differences in the development of the humoral
immune response between pigs that get subclinically infected with PCV2 and pigs that experience
a high level of PCV2-replication which in 3 of 4 experiments led to the development of PMWS.
These observations may contribute to a better understanding of the pathogenesis of a PCV2-
infection.
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Background
Porcine circovirus type 2 is a member of the Circoviridae
family. This family contains small viruses with a circular
single stranded DNA genome, including a number of
avian and mammal viruses that are known to cause per-
sistent infections in their host. Porcine circovirus 2
(PCV2) and chicken anaemia virus are able to maintain a
high level of replication up to one month or longer after
experimental inoculation (Bolin et al., 2001; Imai et al.,
1999) [1,2]. The human hepatitis-related TT-virus, also a
member of the circoviridae family (Nishizawa et al., 1997)
[3], is able to maintain a constant viremia for a period of
more than 3 years in infected patients (Lefrere et al., 2000)
[4]. The ability of these small viruses to persist and repli-
cate for such a long time in their host, indicates a failure
of the host's immunologic response to efficiently recog-
nize and/or remove virus particles or virus-infected cells
from the body.
The economical importance of PCV2 lies in its association
with the postweaning multisystemic wasting syndrome
(PMWS) (Ellis et al., 1998) [5], a condition in weaned pigs
observed for the first time in 1991 (Harding et al., 1996)
[6]. The syndrome is characterized by clinical signs such as
anaemia, jaundice and severe weight loss and histopatho-
logical lesions including lymphocyte depletion and infil-
tration of monocytes in lymphoid tissues. It is generally
accepted that other factors, including other viral infec-
tions such as porcine parvovirus (Allan et al., 2000a) [7]
or porcine reproductive and respiratory syndrome virus
(Allan et al., 2000b) [8] or a stimulation of the immune
system (Krakowka et al., 2001) [9], influence the clinical
outcome of the infection. A high and persisting PCV2-rep-
lication level was found to be a crucial factor in the patho-
genesis of the disease. The demonstration of an intense
PCV2-replication was therefore incorporated in the case
definition of PMWS in order to differentiate the disease
from other chronic disorders leading to the manifestation
of similar clinical symptoms (Segalés and Domingo,
2002) [10].
After experimental PCV2-inoculation, a high variation in
virus replication level and duration has been described
between pigs (Ladekjær-Mikkelsen et al., 2002; Sanchez et
al., 2003) [11,12]. In a subsequent study, the evolution in
PCV2-replication was monitored in individual gnotobi-
otic pigs (Meerts et al., 2005) [13]. During the first two
weeks of the experiment, the evolution of the PCV2-titre
in inguinal lymph nodes of inoculated pigs showed little
variation. At later stages of the infection, two patterns
developed. In most pigs, PCV2-titres decreased between
15 and 21 DPI. One of the PCV2-inoculated pigs, showed
Course of IPMA and SN (sensitive) antibody titres in experimentally PCV2-inoculated gnotobiotic and SPF pigs Figure 1
Course of IPMA and SN (sensitive) antibody titres in experimentally PCV2-inoculated gnotobiotic and SPF 
pigs. Full symbols: pigs with low PCV2 replication (gnotobiotic) or subclinically infected pigs (SPF); empty symbol: pig with high 
PCV2-replication (gnotobiotic) or PMWS-affected pigs (SPF).
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a dramatic increase in PCV2-replication in this period,
resulting in a significantly higher level of PCV2-replica-
tion at 21 DPI. Similar observations were made in other
studies (Ladekjær-Mikkelsen et al., 2002; Sanchez et al.,
2003) [11,12]. From these observations, it could be con-
cluded that not all pigs are equally able to deal with a
PCV2-infection. When the relation between the onset of
the adaptive immune response against PCV2 was moni-
tored in these pigs, an interesting observation was made.
Using a sensitive PCV2-neutralization assay, PCV2-neu-
tralizing antibodies could be detected in all PCV2-inocu-
lated pigs starting from 15 DPI, except in the pig with high
PCV2-replication (Meerts et al., 2005) [13]. This study
suggested a correlation between the absence or delayed
production of PCV2-neutralizing antibodies and an
increased level of replication of the virus in experimen-
tally inoculated pigs. The latter study was performed in
gnotobiotic piglets. Previously, it has been shown that the
adaptive immune response against viral infections in
gnotobiotic pigs which are raised in a sterile environment
may deviate to some extent from the response of pigs in a
conventional environment (Mehrazar et al., 1993; Butler
et al., 2002; Souza et al., 2004) [14-16]. Therefore, the
observation made in PCV2-inoculated gnotobiotic piglets
should be confirmed in naturally infected and experimen-
tally inoculated conventional pigs.
The aim of the present study was to investigate whether
the lack of PCV2-neutralizing antibodies could also be
found in naturally or experimentally reproduced PMWS-
affected pigs and to characterize more in detail the
humoral immune response against PCV2 in PMWS-
affected and healthy animals.
Results
Total PCV2-specific and PCV2-neutralizing antibody titres 
in experimentally inoculated gnotobiotic pigs
The total anti-PCV2 antibody profiles in experimentally
inoculated gnotobiotic and SPF pigs are shown in Figure
1. In this figure, results of the gnotobiotic pigs were pre-
sented in two groups based on the virological outcome of
the infection. In gnotobiotic pigs no antibodies were
detected before 15 DPI. Antibody titres increased in a
time-dependent manner until the end of the study.
With the Classical SN, no PCV2-neutralizing antibodies
were detected in any pig until the end of the study at 21
DPI. Therefore, the sensitive SN was applied. With this
assay, PCV2-neutralizing antibodies were detected in
gnotobiotic pigs starting from the same time point when
anti-PCV2 antibodies were detected with the IPMA (15
DPI). In seven gnotobiotic pigs (pigs with low PCV2-rep-
lication) the evolution of PCV2-neutralizing antibody
titres followed the evolution of the total anti-PCV2 anti-
body titre. However, one gnotobiotic pig (the pig with
high PCV2-replication) showed a PCV2-neutralizing anti-
body profile that significantly differed from its total anti-
PCV2 antibody pattern and from the neutralizing anti-
body pattern observed in the other pigs. In this pig no sig-
nificant PCV2-neutralizing antibodies could be detected
using the sensitive SN at any time during the study.
Total PCV2-specific and PCV2-neutralizing antibody titres 
in experimentally inoculated conventional SPF pigs
The total anti-PCV2 antibody profiles in experimentally
inoculated conventional SPF pigs are shown in Figure 1.
In this figure, results of these pigs were presented in two
groups based on the clinical outcome of the infection. In
SPF pigs the first anti-PCV2 antibodies were detected at 10
DPI. At that time PMWS-affected SPF pigs showed signifi-
cantly higher IPMA titres compared to their healthy group
mates (p = 0.037). Only in one PMWS-affected SPF pig
(pig 3), a plateau was reached starting from 10 DPI. At 21
DPI, the antibody titre in this pig was low (2.7 log4) com-
pared to the other pigs (5.7 – 6.7 log4).
With the Classical SN, similar as in gnotobiotic pigs, no
PCV2-neutralizing antibodies were detected until the end
of the study thus the sensitive SN was applied. With this
assay, PCV2-neutralizing antibodies were detected start-
ing from 10 DPI.
In six SPF pigs (pigs that did not develop PMWS) the evo-
lution in PCV2-neutralizing antibody titres followed the
evolution of the total anti-PCV2 antibody titre. In these
pigs, the PCV2-neutralizing antibody titres increased in a
time dependent manner until the end of the study. At the
end of the study (21 dpi) up to 98% PCV2-neutralization
was observed in some pigs. The four SPF pigs that devel-
oped PMWS showed a PCV2-neutralizing antibody pro-
file that significantly differed from their total anti-PCV2
antibody pattern and from the neutralizing antibody pat-
tern observed in the other pigs in the experiment. These
pigs showed a small peak in PCV2-neutralization at 10
DPI (40 to 56%) but afterwards the neutralization titres
declined towards the time point at which the last serum
samples could be collected (two pigs died at 20 DPI) or
until neutralization could no longer be detected (2 pigs at
21 DPI). SN-titres in PMWS-affected SPF pigs were signif-
icantly lower compared to SN titres in healthy pigs at 14
(p = 0.011) and 21 DPI (p = 0.046).
Total PCV2-specific and PCV2-neutralizing antibody titres 
in naturally PCV2-infected pigs
Total PCV2-specific antibody titres (IPMA) and PCV2-
neutralizing titres (classical SN) detected in naturally
PCV2-infected pigs derived from a Belgian and a Danish
field study are presented in Figure 2. In this figure, results
of pigs were presented in two groups based on the clinical
outcome of the infection. All piglets enclosed in both fieldBMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
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studies showed maternally derived antibody (MDA) titres
between 3.7 and 6.7 log4. A gradual decline of total anti-
PCV2 antibody titres was detected in all pigs except one
pig (pig 6) in the Danish study. Seroconversion was
observed in the Danish pigs between 3 and 6 weeks after
mingling and in the Belgian pigs between 6 and 12 weeks
of age. In the Danish study, IPMA antibody titres at 6
weeks post mingling were generally lower in PMWS-
affected pigs, compared to healthy pigs (p = 0.013). How-
ever, this difference could not be demonstrated in the Bel-
gian field study.
At the onset of both field studies, SN titres were found
above the detection limit with the classical SN in all sera
due to the presence of MDA. SN titres at the start of the
studies ranged between 4 and 9. At the start of the study,
no significant differences in SN Ab titres could be
observed between subclinically infected pigs and pigs that
developed PMWS. SN titres decreased in a time-depend-
ent manner during the first weeks of the study. In all but
one subclinically infected pigs in the Danish field study, a
rise in SN titres could be detected before the end of the
study. Such a seroconversion was detected starting from
10 weeks of age in the Belgian study and starting from 3
weeks after mingling in the Danish study. The majority of
the PMWS affected pigs died before they reached the age
at which a rise in SN titres could be detected (1 pig in the
Belgian and 8 pigs in the Danish study). However, one
PMWS-affected pig in the Belgian study and 5 pigs in the
Danish study survived until the end of the study. In none
of these pigs, a rise in SN titres was detected. This resulted
in a significant lower SN-titre in the PMWS affected pigs
in the Danish study (p = 0.005).
Course of PCV2-specific antibody isotype titres in 
experimentally inoculated gnotobiotic and SPF pigs
The titres of specific anti-PCV2 antibody isotypes in
gnotobiotic and SPF pigs are shown in Figure 3. In gnoto-
biotic pigs, the different antibody isotypes generally fol-
lowed the course of the IPMA antibody titres. The IgM,
IgG1 and IgG2 titres detected in the pig that experienced a
high level of PCV2-replication (gnotobiotic pig 3) did not
differ from the titres of the other pigs. In the pig with high
PCV2-replication IgA-type antibodies were detected start-
ing from 15 DPI whereas in the other pigs IgA-type anti-
bodies were detected starting from 10 DPI.
In SPF pigs, a clear difference between PMWS-affected and
healthy pigs was observed in the evolution of IgM-type
antibodies. Between healthy pigs, very little variation was
Course of IPMA and SN (Classical) antibody titres in naturally PCV2-infected pigs in Belgian and Danish field conditions Figure 2
Course of IPMA and SN (Classical) antibody titres in naturally PCV2-infected pigs in Belgian and Danish field 
conditions. Full symbols: subclinically infected pigs; empty symbols: PMWS-affected pigs. Full line: mean antibody titre of sub-
clinically infected pigs; dashed line: mean antibody titre of PMWS-affected pigs. When difference between mean titres was sig-
nificant, the p-value was shown.
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Course of isotype-specific antibody titres in experimentally PCV2-inoculated gnotobiotic and SPF pigs Figure 3
Course of isotype-specific antibody titres in experimentally PCV2-inoculated gnotobiotic and SPF pigs. Full sym-
bols: pigs with low PCV2 replication (gnotobiotic) or subclinically infected pigs (SPF); empty symbol: pig with high PCV2-repli-
cation (gnotobiotic) or PMWS-affected pigs (SPF). Full line: mean antibody titre of the pigs with low PCV2 replication 
(gnotobiotic) or healthy pigs (SPF). Dashed line: antibody titre of pig with high PCV2-replication (gnotobiotic) or mean titre of 
PMWS-affected pigs (SPF). When the difference between the mean titres was significant, the p-value was shown.BMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
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detected in IgM titres. Starting from 10 DPI, anti-PCV2
IgM-antibodies were detected and titres steadily increased
until the end of the study. In 2 out of 4 PMWS-affected
pigs, IgM antibodies were detected starting from 7 DPI. At
10 DPI, IgM titres in PMWS-affected pigs were signifi-
cantly higher than IgM titres in healthy pigs (p = 0.018).
After 10 DPI, IgM titres in PMWS-affected pigs decreased
towards the end of the study. At 21 DPI, IgM titres in
PMWS-affected pigs were significantly lower compared to
IgM titres in healthy pigs (p = 0.035).
IgG1, IgG2 and IgA titres in SPF pigs generally followed
the profiles of the IPMA antibody titres. Titres increased
until the end of the study. At 21 DPI, the mean titres of
these antibody isotypes in PWMS-affected pigs were lower
compared to the titres in healthy pigs. However, only for
the IgG2 titres, these differences were found to be signifi-
cant (p = 0.039).
Course of PCV2-specific antibody isotype titres in naturally 
PCV2-infected pigs
In naturally PCV2-infected pigs, similar observations were
made as in the experimentally inoculated animals. In
both field studies, the course of the IgM-type antibodies
against PCV2 differed between healthy and PMWS-
affected pigs. In healthy pigs, IgM titres were found to
increase steadily towards the end of the study, resulting in
high IgM titres even at 14 weeks of age, 6 weeks after the
first IgM antibodies were detected in some pigs. PMWS-
affected pigs had low titres of IgM antibodies. The mean
IgM titres in PMWS-affected pigs in the Danish study were
significantly lower compared to the titres in healthy pigs
(p = 0.001). IgG1, IgG2 and IgA titres followed the course
of the IPMA antibody titres. It was observed that the mean
of these titres in PMWS-affected pigs was always lower
compared to the mean titre in healthy pigs. However,
these differences were not significant. Due to the limited
number of PMWS-affected pigs in the Belgian field study,
it was not possible to detect significant differences but it
was clear that also in this study IgM titres in the affected
pigs were much lower compared to titres in their healthy
littermates.
Discussion
In the present study, it was shown that the absence of
PCV2-neutralizing antibodies was correlated with high
PCV2-replication and with PCV2-related disease (PMWS)
if present.
Neutralizing antibodies have important functions in the
defence of animals and humans against viral infections.
Starting from the moment they appear, neutralizing anti-
bodies bind and neutralize the virus and prevent further
spread in the body by inhibiting attachment and infection
of new cells. It has been shown that neutralizing antibod-
ies against many viruses are more rapidly induced during
the immune response and reach higher titres compared to
antibodies against other viral epitopes (Bachmann and
Zinkernagel, 1997) [26]. In contrast, neutralizing anti-
bodies against PCV2 could only be detected starting from
10 dpi by using a particularly sensitive SN assay (Meerts et
al., 2005) [13]. These SN titres rose slowly until they could
be detected with the classical SN assay starting from 4
weeks after inoculation (Pogranichnyy et al., 2000) [24].
The slow induction of neutralizing antibodies is a very
effective mechanism for the virus to ensure a long period
of replication in its host. In previous work, the observa-
tion was made that an increased replication of the virus in
one pig, was correlated with a lack of neutralizing anti-
body production (Meerts et al., 2005) [13]. In the present
study, it was confirmed that the absence of PCV2-neutral-
izing antibodies is indeed a recurring phenomenon in
pigs with high PCV2-replication. In experimentally PCV2-
inoculated SPF pigs and in two field studies, a good corre-
lation was observed between the absence or low titres of
neutralizing antibodies against PCV2 and the occurrence
of a high virus replication and the development of PMWS.
This observation reveals a possible mechanism that allows
the virus to replicate to a higher extent in a limited
number of pigs. These pigs seem to be unable to recognize
or produce antibodies against the epitope(s) that is (are)
involved in the neutralization of the virus. With relation
to other viral infections such as pseudorabies virus (Jacobs
and Kimman, 1994) [27], influenza virus (Lambkin and
Dimmock, 1995) [28] or human rotavirus (Green et al.,
1990) [29], it has been shown that different animals do
not all recognize the same epitopes. Various syndromes
have already been ascribed to the inability of certain indi-
viduals to recognize certain epitopes (susceptibility to
mastitis (Lunden et al., 1990) [30], clinical outcome of
Marek's disease virus (Wakenell et al., 1996) [31]). The
susceptibility to these syndromes is highly genetically
determined. It has been demonstrated previously that the
prevalence of PMWS highly differs between regions. Since
contemporary pig industry still uses region-specific
breeds, this could be interpreted as an indication that
PMWS would be partly genetically determined. Therefore,
it would be worthwhile to check for a similar mechanism
in the recognition of PCV2-neutralizing epitope and the
subsequent influence on the susceptibility of the host to
PMWS.
In the present study, it was shown that maternally derived
antibodies in serum were able to neutralize PCV2-infec-
tion in an in vitro SN assay but could not avoid PCV2-
infection of the pig since seroconversion was observed in
pigs with maternal SN titres as high as 6 log2. When look-
ing at the total antibody titres (IPMA) in the field studies,
it was observed that seroconversion against PCV2 never
occurred in pigs before weaning at the age of 4 weeks (Bel-BMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
Page 7 of 11
(page number not for citation purposes)
gian field study) or before the pigs were mingled (Danish
study).
In experimentally inoculated SPF pigs that developed
PMWS, a small and transient peak in PCV2-neutralization
was observed at 10 DPI. It was observed that these pigs
also showed a peak of IgM titres at that same time point.
The IgM antibodies in these pigs did not lead to the pro-
duction of neutralizing IgG or IgA antibodies, which may
indicate that the neutralizing epitope was not targeted by
the humoral immune response. However, the pro-
nounced B-cell lymphopenia that was observed in these
pigs (Nielsen et al., 2003) [32] may also constitute an
important factor in the mechanism causing these changes
in the humoral immune response. The parallel evolution
of the SN and IgM titres in these pigs suggests that the IgM
antibodies might be responsible for the low level of PCV2-
neutralization that was observed at 10 DPI. Possibly IgM
antibodies which are directed against non-neutralizing
epitopes, are able to neutralize PCV2 to some extent by
sterical hindrance. Indeed, IgM antibodies are secreted in
a pentamere formation that is much larger compared to
any other antibody isotype. This pentamere form contains
10 Fab fragments that would enable it to bind PCV2 at dif-
ferent sites. In PMWS-affected pigs in the Danish field
study, a peak in IgM antibodies was not detected probably
because time intervals between the different blood collec-
tions were too long (3 weeks). When comparing IgM pro-
files in both experimental studies, it is observed that in the
gnotobiotic pig with high PCV2-replication, low IgM titres
were detected until the end of the study. In general the
humoral immune response in gnotobiotic pigs was
delayed compared to the SPF pigs, which might be the rea-
son that no decrease in IgM titres was observed in this pig.
The low IgM titres in this gnotobiotic pig might corre-
spond to the slight increase in PCV2-neutralization (up to
16% whereas in other pigs they reached 97%) that was
observed in this pig. This slight neutralization however,
was not significantly different compared to the result
obtained from serum of the same pig before inoculation.
In contrast with titres in PMWS-affected pigs, IgM titres in
subclinically infected animals persisted and even
increased until the end of the study. After a viral infection,
IgM-type antibodies are the first antibodies that are being
produced. Generally, the plasma cells that produce these
antibodies go through an isotype switch and start produc-
ing other isotypes of antibodies resulting a down-regula-
tion of IgM production (Esser and Radbruch, 1997) [33].
A persistence of IgM type antibodies has already been
described during the immune response against other
viruses such as the coronavirus responsible for the severe
acute respiratory syndrome in humans (Woo et al., 2004)
[34] or the human parvovirus B19 (Yeagashi et al., 1989)
[35]. However, the mechanism of this prolonged presence
of IgM antibodies has not been defined yet. It is known
that in older animals such as breeding sows, exceptionally
high IPMA antibody titres against PCV2 can be found
compared to antibody titres against other viruses. It may
be hypothesized that the persistent presence of IgM lies at
the base of this observation.
Although a clear difference in the course of IgM antibodies
was observed between healthy and PMWS-affected pigs,
the isotype switch occurred in both kinds of pigs at the
same time point since other antibody isotypes were
detected starting from the same time point. In PMWS-
affected pigs, titres of other antibody isotypes against
PCV2 were somewhat lower compared to titres in healthy
pigs at the end of the studies. These differences, although
hard to explain, indicate that some important changes in
the humoral immune response occur. Possibly they are
related to the fact that PCV2 is able to cause a severe deple-
tion of especially the B-cells (Sanchez et al., 2004; Nielsen
et al., 2003) [32,36]. Whether these changes are important
in the induction of PMWS or are merely a consequence of
it, remains unclear.
Methods
Sera
In the present study, sera from four different studies were
included. In these studies, pigs got experimentally or nat-
urally infected with PCV2. In three out of four studies
PMWS was observed and diagnosed as proposed by Sor-
den (2000) [17] which implies the combined presence of
the clinical symptoms and histopathological lesions asso-
Table 1: Sera used in the present study
Number of pigs with
Origin of pigs PCV2-infection Serum samples available high* PCV2-replication clinical signs of PMWS
Gnotobiotic experimental 0, 10, 15, 21 DPI 1/8 0/8
SPF conventional experimental 0, 7, 10, 14, 21 DPI 4/10 4/10
Field cases (Belgium) natural 4, 6, 8, 10, 12, 14 weeks of age NA** 2/10
Field cases (Denmark) natural 0, 3, 6, 9 weeks after mingling NA** 13/26
high*: = 104.3 TCID50/gram lymph node
NA**: not available since PCV2-titres were not obtained from healthy pigs. All PMWS-affected pigs did contain high titres of PCV2BMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
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ciated with PMWS and the detection of PCV2 in these
lesions. An overview of the used sera is shown in Table 1.
A first set of sera was derived from two experimental
PCV2-inoculation studies, one performed in 19-day-old
gnotobiotic pigs and another performed in 21-day-old
PCV2-negative conventional specific pathogen free (SPF)
Course of isotype-specific antibody titres in naturally PCV2-infected pigs Figure 4
Course of isotype-specific antibody titres in naturally PCV2-infected pigs. Full symbols: subclinically infected pigs, 
empty symbols: PMWS-affected pigs. Full line: mean antibody titre of healthy pigs, dashed line: mean antibody titre of PMWS-
affected pigs. When the difference between the mean values was significant, the p-value was shown.BMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
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pigs. A second set of sera originated from two field studies
performed in Belgium and Denmark.
1. Experimentally inoculated gnotobiotic pigs (Meerts et
al., 2005) [13]: 8 gnotobiotic piglets were inoculated with
PCV2 (104.3 TCID50 of strain 1121 intraperitoneally and
oronasally) at 19 days of age. Blood was taken from these
piglets at 0, 10, 15 and 21 days post inoculation (DPI). In
this experiment, PMWS was not observed but one pig
showed a high level of PCV2-replication at the end of the
experiment (104.3 TCID50/g inguinal lymph node) com-
pared to the other PCV2-inoculated pigs (average of 102.3
TCID50/g inguinal lymph node).
2. Experimentally inoculated SPF pigs (Ladekjær-
Mikkelsen et al., 2002) [11]: 10 PCV2-negative SPF-pigs
were inoculated with PCV2 (106.3 TCID50 of strain OSU3
intranasally) at the age of 3 weeks. At the time point of
inoculation, 5 pigs were injected with keyhole limpet
hemocyanin in incomplete Freunds adjuvant. However,
this treatment could not be associated with any significant
difference in clinical, immunological or virological out-
come of the infection. Blood was taken at 0, 3, 7, 10, 14
and 21 DPI. Four out of 10 inoculated pigs developed
PMWS and died or were euthanized before the end of the
study (2 pigs at 20 DPI, 2 pigs at 21 DPI). These pigs
showed high titres of PCV2 at the time they died (average
of 105.1 TCID50/g inguinal and prescapular lymph node).
At the end of the study, no PCV2 could be isolated from
lymph nodes of pigs that did not develop PMWS.
3. Belgian field study (Meerts et al., 2004) [18]: during this
study, blood was taken every two weeks from 9 piglets
originating from 2 litters on PMWS-affected farms in Bel-
gium. This serological follow-up started before the
appearance of PMWS-related clinical signs (4 weeks of
age) and ended at 14 weeks of age, the age after which new
cases of PMWS seldom occur. In each litter, one piglet
developed PMWS during the study and died before the
end of the study.
4. Danish field study (Kristensen et al., 2004) [19]: in this
field study, pigs originating from PMWS-affected and
healthy farms were weaned and brought to the same unit.
Blood was taken at the day the pigs were mingled (day 0)
and 3 and 6 weeks later. During the study, a number of
pigs from healthy farms developed PMWS and some of
these affected pigs had to be euthanized before the end of
the study. In the present study, sera were included origi-
nating from 13 subclinically infected pigs (healthy) and
13 pigs that developed PMWS during the follow-up. Eight
affected pigs died before the last blood sampling occurred,
five pigs developed PMWS but survived until the end of
the study.
Immunoperoxidase monolayer assay (IPMA)
The total titre of anti-PCV2 antibodies (IPMA-Ab) was
determined using the IPMA as described previously by
Labarque et al. (2000) [20]. This assay does not discrimi-
nate between neutralizing and non-neutralizing antibod-
ies nor does it detect specific antibody isotypes.
Isotype-specific IPMA
The individual levels of antibody isotypes IgG1, IgG2, IgA
and IgM against PCV2 in sera were determined by an iso-
type specific IPMA. PCV2-infected PK-15 cell cultures
were fixed and incubated with 4-fold dilution series of the
tested sera. After 90 minutes of incubation, the cell cul-
tures were washed thoroughly (4 times in phosphate buff-
ered saline + 0,1% Tween 80) to remove unbound
antibodies. Afterwards, mouse monoclonal antibodies
directed against porcine IgM, IgA, IgG1 or IgG2 were
added and incubated for 60 minutes (Labarque et al.,
2000b) [21]. After additional washing, peroxidase-conju-
gated goat polyclonal antibodies against mouse immu-
noglobulins were added (Goat-anti-Mouse-HRP, DAKO)
and peroxidase activity was visualized by adding 3-amino-
5-ethylcarbazole.
Classical seroneutralization assay (Classical SN)
With this assay, PCV2-neutralizing antibodies were
detected using the classical protocol as has been described
for many other viruses (Nauwynck et al., 1999; Van Reeth
et al., 2003) [22,23]. Two-fold dilution series of the tested
serum were prepared in MEM. The lowest dilution used in
the test was 50% (1:1 dilution of serum in MEM). Twenty-
five µl of these serial diluted sera were incubated for 1
hour at 37°C with a fixed number of infectious particle of
PCV2 (103.7 TCID50 of strain Stoon-1010 in 25 µl). This
mixture was afterwards added to 50% confluent PK-15
cells in a 96-well plate. After 1 hour of incubation at 37°C,
the inoculum was removed, cell cultures were washed
twice with MEM and culture medium was added. Inocu-
lated cultures were further incubated at 37°C in an atmos-
phere containing 5% CO2. After 36 hours of incubation,
cells were fixed and stained with the immunoperoxidase
assay as described before. By light microscopy, it was
observed at which concentration of the serum, PCV2-pos-
itive cells could still be detected. The neutralization titre
with this assay was calculated as the reciprocal of the high-
est dilution of the serum that was able to completely block
PCV2-infection in PK-15 cells. Thus the lowest dilution
contained 25% serum (1:1 dilution of serum + equal vol-
ume of PCV2 stock), thereby the detection limit of this
assay was 2 log2.
Sensitive seroneutralization assay (sensitive SN)
It has previously been shown that PCV2-neutralizing anti-
body titres are only slowly induced (Pogranychnyy et al.,
2000) [24]. Therefore, a more sensitive technique wasBMC Veterinary Research 2006, 2:6 http://www.biomedcentral.com/1746-6148/2/6
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developed. When no PCV2-neutralizing antibodies could
be detected with the Classical SN, PCV2-neutralizing anti-
bodies were detected by using the more sensitive seroneu-
tralization described by Meerts et al. (2005) [13]. A similar
neutralization assay had previously also been used to
detect neutralizing antibodies against porcine reproduc-
tive and respiratory syndrome virus (Delputte et al., 2005)
[25]. Briefly, a standard infectious dose of PCV2 (103.7
TCID50 of strain Stoon-1010) was incubated for 1 hour at
37°C with 25% of the serum. Afterwards, this virus-serum
mixture was inoculated on PCV-negative PK-15 cells. After
1 hour, the inoculum was removed, cell cultures were
washed 2 times, new cell medium was added and cultures
were maintained at 37°C in the presence of 5% CO2.
After 36 hours of incubation, cells were fixed and stained
for PCV2 antigens using an immunoperoxidase tech-
nique. The number of PCV2-infected cells was counted
and compared to the number of infected cells in a PK-15
culture inoculated with a PCV2 stock treated with the
serum of the pig before inoculation. The result of this
seroneutralization assay was expressed as a percentage of
reduction of PCV2-infection.
Statistical analysis
Statistical significance of differences was calculated using
the Kruskal-Wallis test. Differences were considered sig-
nificant when p < 0.05.
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